Adela Hasa-Moreno

Regulatory Affairs, Associate Director at ALX Oncology - Burlingame, California, United States

Adela Hasa-Moreno's Colleagues at ALX Oncology
Athanasios Tsiatis

Senior Vice President, Clinical Development

Contact Athanasios Tsiatis

Susan Vermeir

Vice President, Regulatory Affairs

Contact Susan Vermeir

Susan Vermeir

VP, Pharmaceutical Regulatory Affairs

Contact Susan Vermeir

Hanako Daino-Laizure

Senior Scientist Discovery Biology

Contact Hanako Daino-Laizure

View All Adela Hasa-Moreno's Colleagues
Adela Hasa-Moreno's Contact Details
HQ
["(353) 161-8000"]
Location
Company
ALX Oncology
Adela Hasa-Moreno's Company Details
ALX Oncology logo, ALX Oncology contact details

ALX Oncology

Burlingame, California, United States • 11 - 50 Employees
Biotechnology

ALX Oncology is a publicly traded, clinical-stage immuno-oncology company focused on helping patients fight cancer by developing therapies that block the CD47 checkpoint pathway and bridge the innate and adaptive immune system. ALX Oncology's lead product candidate, evorpacept (also known as ALX148), is a next generation CD47 blocking therapeutic that combines a high-affinity CD47 binding domain with an inactivated, proprietary Fc domain. Evorpacept has demonstrated promising clinical responses across a range of hematologic and solid malignancies in combination with a number of leading anti-cancer agents.

Details about ALX Oncology
Frequently Asked Questions about Adela Hasa-Moreno
Adela Hasa-Moreno currently works for ALX Oncology.
Adela Hasa-Moreno's role at ALX Oncology is Regulatory Affairs, Associate Director.
Adela Hasa-Moreno's email address is ***@alxoncology.com. To view Adela Hasa-Moreno's full email address, please signup to ConnectPlex.
Adela Hasa-Moreno works in the Biotechnology industry.
Adela Hasa-Moreno's colleagues at ALX Oncology are Connie Lu, Athanasios Tsiatis, Susan Vermeir, Susan Vermeir, Yasmina Abdiche, Danielle Fontaine, Hanako Daino-Laizure and others.
Adela Hasa-Moreno's phone number is ["(353) 161-8000"]
See more information about Adela Hasa-Moreno